These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 22005315)

  • 21. Nonsteroidal antiinflammatory drug use and cardiovascular risks after coronary stent implantation.
    Schmidt M; Pedersen L; Maeng M; Lassen JF; Lash TL; Nielsen TT; Sørensen HT
    Pharmacotherapy; 2011 May; 31(5):458-68. PubMed ID: 21923427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of dose potency in the prediction of risk of myocardial infarction associated with nonsteroidal anti-inflammatory drugs in the general population.
    García Rodríguez LA; Tacconelli S; Patrignani P
    J Am Coll Cardiol; 2008 Nov; 52(20):1628-36. PubMed ID: 18992652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous assessment of short-term gastrointestinal benefits and cardiovascular risks of selective cyclooxygenase 2 inhibitors and nonselective nonsteroidal antiinflammatory drugs: an instrumental variable analysis.
    Schneeweiss S; Solomon DH; Wang PS; Rassen J; Brookhart MA
    Arthritis Rheum; 2006 Nov; 54(11):3390-8. PubMed ID: 17075817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction and cerebrovascular accident.
    Abraham NS; El-Serag HB; Hartman C; Richardson P; Deswal A
    Aliment Pharmacol Ther; 2007 Apr; 25(8):913-24. PubMed ID: 17402995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonsteroidal antiinflammatory drugs and the risk of myocardial infarction in the general population.
    García Rodríguez LA; Varas-Lorenzo C; Maguire A; González-Pérez A
    Circulation; 2004 Jun; 109(24):3000-6. PubMed ID: 15197149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of acute myocardial infarction with real-world NSAIDs depends on dose and timing of exposure.
    Bally M; Beauchamp ME; Abrahamowicz M; Nadeau L; Brophy JM
    Pharmacoepidemiol Drug Saf; 2018 Jan; 27(1):69-77. PubMed ID: 29171096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk.
    Solomon DH; Avorn J; Stürmer T; Glynn RJ; Mogun H; Schneeweiss S
    Arthritis Rheum; 2006 May; 54(5):1378-89. PubMed ID: 16645966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence.
    Jacobs EJ; Rodriguez C; Mondul AM; Connell CJ; Henley SJ; Calle EE; Thun MJ
    J Natl Cancer Inst; 2005 Jul; 97(13):975-80. PubMed ID: 15998950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between nonnaproxen NSAIDs, COX-2 inhibitors and hospitalization for acute myocardial infarction among the elderly: a retrospective cohort study.
    Rahme E; Watson DJ; Kong SX; Toubouti Y; LeLorier J
    Pharmacoepidemiol Drug Saf; 2007 May; 16(5):493-503. PubMed ID: 17086567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular and Bleeding Risks Associated With Nonsteroidal Anti-Inflammatory Drugs After Myocardial Infarction.
    Kang DO; An H; Park GU; Yum Y; Park EJ; Park Y; Jang WY; Kim W; Choi JY; Roh SY; Na JO; Kim JW; Kim EJ; Rha SW; Park CG; Seo HS; Choi CU
    J Am Coll Cardiol; 2020 Aug; 76(5):518-529. PubMed ID: 32731930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular events associated with the use of four nonselective NSAIDs (etodolac, nabumetone, ibuprofen, or naproxen) versus a cyclooxygenase-2 inhibitor (celecoxib): a population-based analysis in Taiwanese adults.
    Huang WF; Hsiao FY; Wen YW; Tsai YW
    Clin Ther; 2006 Nov; 28(11):1827-36. PubMed ID: 17213003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Underutilization of preventive strategies in patients receiving NSAIDs.
    Sturkenboom MC; Burke TA; Dieleman JP; Tangelder MJ; Lee F; Goldstein JL
    Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii23-31. PubMed ID: 14585915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-aspirin NSAIDs, cyclooxygenase-2 inhibitors and risk for cardiovascular events-stroke, acute myocardial infarction, and death from coronary heart disease.
    Roumie CL; Choma NN; Kaltenbach L; Mitchel EF; Arbogast PG; Griffin MR
    Pharmacoepidemiol Drug Saf; 2009 Nov; 18(11):1053-63. PubMed ID: 19637402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. National mortality following upper gastrointestinal or cardiovascular events in older veterans with recent nonsteroidal anti-inflammatory drug use.
    Abraham NS; Castillo DL; Hartman C
    Aliment Pharmacol Ther; 2008 Jul; 28(1):97-106. PubMed ID: 18397385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of proton pump inhibitor treatment on gastrointestinal bleeding associated with non-steroidal anti-inflammatory drug use among post-myocardial infarction patients taking antithrombotics: nationwide study.
    Schjerning Olsen AM; Lindhardsen J; Gislason GH; McGettigan P; Hlatky MA; Fosbøl E; Køber L; Torp-Pedersen C; Lamberts M
    BMJ; 2015 Oct; 351():h5096. PubMed ID: 26481405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of NSAID treatment on cardiovascular risk - insight from Danish observational data.
    Schjerning Olsen AM; Fosbøl EL; Gislason GH
    Basic Clin Pharmacol Toxicol; 2014 Aug; 115(2):179-84. PubMed ID: 24690187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in cardiovascular safety with non-steroidal anti-inflammatory drug therapy-A nationwide study in patients with osteoarthritis.
    Barcella CA; Lamberts M; McGettigan P; Fosbøl EL; Lindhardsen J; Torp-Pedersen C; Gislason GH; Olsen AS
    Basic Clin Pharmacol Toxicol; 2019 May; 124(5):629-641. PubMed ID: 30484960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors and prognostic impact of recurrent myocardial infarction in patients with left ventricular dysfunction, heart failure, or both following a first myocardial infarction.
    Thune JJ; Signorovitch JE; Kober L; McMurray JJ; Swedberg K; Rouleau J; Maggioni A; Velazquez E; Califf R; Pfeffer MA; Solomon SD
    Eur J Heart Fail; 2011 Feb; 13(2):148-53. PubMed ID: 21037250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of post-operative clopidogrel treatment in patients revascularized with coronary artery bypass grafting after myocardial infarction.
    Sørensen R; Abildstrøm SZ; Hansen PR; Hvelplund A; Andersson C; Charlot M; Fosbøl EL; Køber L; Madsen JK; Gislason GH; Torp-Pedersen C
    J Am Coll Cardiol; 2011 Mar; 57(10):1202-9. PubMed ID: 21371637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postoperative non-steroidal anti-inflammatory drugs and colorectal anastomotic leakage. NSAIDs and anastomotic leakage.
    Klein M
    Dan Med J; 2012 Mar; 59(3):B4420. PubMed ID: 22381097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.